Home  >  Products  >  MMP26 (matrix metallopeptidase 26) Blocking Peptide (the C terminal of MMP26)(100ug)
MMP26 (matrix metallopeptidase 26) Blocking Peptide (the C terminal of MMP26)(100ug)

MMP26 (matrix metallopeptidase 26) Blocking Peptide (the C terminal of MMP26)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MMP26 Antibody(ARP57558_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57558
Size: 100ug
Weight: 19kDa
Gene: 56547
Format: Lyophilized powder
Target: Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein degrades type IV collagen, fibronectin, fibrinogen, casein, vitronectin, alpha 1-antitrypsin, alpha 2-macroglobulin, and insulin-like growth factor-binding protein 1, and activates MMP9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain.
Alternative names: MGC126590; MGC126592
See Full Product Listings >